Smith Group Asset Management, LLC Moderna, Inc. Transaction History

Smith Group Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $123,727 - $185,885	-1,780 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $126,459 - $206,365	560 Added 45.9%	1,780 $452,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $270,718 - $591,053	1,220 New	1,220 $470,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Smith Group Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith Group Asset Management, LLC with notifications on news.